Skip to main content
SpringerLink
Log in

Caring for Patients During and After Immunotherapy Treatment

  • Chapter
  • First Online:
Caring for Patients with Mesothelioma: Principles and Guidelines

  • 313 Accesses

Abstract

Caring for mesothelioma patients during and after immunotherapy treatment is complex and requires incredible expertise and knowledge about immunotherapy and its potential toxicities. Caring for mesothelioma patients requires an interdisciplinary team of experts as well as a nurse experienced in caring for mesothelioma patients. Mesothelioma-specialized nurses provide a necessary layer of communication and support when patients are treated with immunotherapy on clinical trials and deliver the high level of care and coordination necessary for these patients. Immunotherapy has a very different profile of toxicities and requires nursing as well as a team of specialists to appropriately treat and resolve those toxicities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Calabrò L, Morra A, Fosatti F, et al. Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma. An open-label, single arm, phase 2 study. Lancet Respir Med. 2015;3:301–9.

    Article  CAS  Google Scholar 

  • Kindler H, Karrison T, Carol Tan YH, Rose B, Ahmad M, Straus C, Sargis R, Seiwert T. Phase II trial of pembrolizumab in patients with malignant mesothelioma: interim analysis. J Thorac Oncol. 2017;12:S293. abstract OA13.02.

    Article  Google Scholar 

  • Oncology Nursing Society. 2016 oncology clinical trials nurse competencies; 2016. Retrieved from https://www.ons.org/sites/default/files/OCTN_Competencies_FINAL.PDF

  • Thompson J. New NCCN guidelines: recognition and management of immunotherapy-related toxicity. J Natl Compr Canc Netw. 2018;16:594–6. https://doi.org/10.6004/jnccn.2018.0047.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Chicago, Chicago, IL, USA

    Buerkley Rose

Authors
  1. Buerkley Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Buerkley Rose .

Editor information

Editors and Affiliations

  1. Mesothelioma Applied Research Foundation, Alexandria, VA, USA

    Mary Hesdorffer

  2. City University of New York, Graduate Center, New York, NY, USA

    Gleneara E. Bates-Pappas

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rose, B. (2019). Caring for Patients During and After Immunotherapy Treatment. In: Hesdorffer, M., Bates-Pappas, G. (eds) Caring for Patients with Mesothelioma: Principles and Guidelines. Springer, Cham. https://doi.org/10.1007/978-3-319-96244-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-96244-3_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-96243-6

  • Online ISBN: 978-3-319-96244-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation